[1]
2010. Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes. Farmeconomia. Health economics and therapeutic pathways. 11, 2 (Jun. 2010), 83–89. DOI:https://doi.org/10.7175/fe.v11i2.186.